Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Kidney transplant recipients see lower IgG production after COVID-19 jab

Kidney transplant recipients see lower IgG production after COVID-19 jab

14 Oct 2022 bởiTristan Manalac

Vaccination against COVID-19 seems to be less effective among kidney transplant recipients, according to a recent study. Cessation or reduction of immunosuppressive treatments may help increase the production of immunoglobulin (Ig)G in these patients.

Kidney transplant recipients see lower IgG production after COVID-19 jab

14 Oct 2022
Cefepime/enmetazobactam effective for suspected gram-negative complicated UTI

Cefepime/enmetazobactam effective for suspected gram-negative complicated UTI

11 Oct 2022 bởiJairia Dela Cruz

Patients with complicated urinary tract infection (UTI) or acute pyelonephritis caused by gram-negative pathogens may fare better with cefepime/enmetazobactam than with piperacillin/tazobactam, as the former is associated with a greater likelihood of achieving treatment success, according to the results of a phase III trial.

Cefepime/enmetazobactam effective for suspected gram-negative complicated UTI

11 Oct 2022
ADT suppresses levels of several androgen precursor steroids

ADT suppresses levels of several androgen precursor steroids

04 Oct 2022 bởiTristan Manalac

In prostate cancer patients, the initiation of androgen deprivation therapy (ADT) lowers the concentrations of 13 circulating steroids, according to a new study.

ADT suppresses levels of several androgen precursor steroids

04 Oct 2022
Secondary kidney stones: to remove or not?

Secondary kidney stones: to remove or not?

30 Sep 2022 bởiAudrey Abella

Pre-emptive removal of secondary* kidney stones during surgery to remove primary** stones led to fewer relapses and a similar number of emergency-department (ED) visits related to the surgery compared with leaving the secondary stones in place, a study suggests.

Secondary kidney stones: to remove or not?

30 Sep 2022
Apixaban better than enoxaparin for extended-duration VTE prophylaxis after surgery

Apixaban better than enoxaparin for extended-duration VTE prophylaxis after surgery

29 Sep 2022 bởiStephen Padilla

Apixaban is not inferior to enoxaparin for extended-duration venous thromboembolic event (VTE) prophylaxis (EP) following urologic oncology surgery, reveals a study. In addition, apixaban is associated with fewer major complications and compliance-related adverse events.

Apixaban better than enoxaparin for extended-duration VTE prophylaxis after surgery

29 Sep 2022
Urological prosthetic surgery: Which men are at risk of postoperative thromboembolism?

Urological prosthetic surgery: Which men are at risk of postoperative thromboembolism?

27 Sep 2022
Radical prostatectomy tied to higher survival than radiotherapy in prostate cancer

Radical prostatectomy tied to higher survival than radiotherapy in prostate cancer

27 Sep 2022
Poor sleep quality may increase odds of erectile dysfunction

Poor sleep quality may increase odds of erectile dysfunction

26 Sep 2022

Sleep parameters are robust predictors of erectile dysfunction (ED), suggesting that poor sleep quality contributes to a greater likelihood of ED, reveals a study.

Poor sleep quality may increase odds of erectile dysfunction

26 Sep 2022